Frontlight ResearchEarly access
Trial site
Montpellier
- 12running trials
- 6closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis4 trials
- Metastatic breast cancer3 trials
- Chronic myeloid leukaemia2 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia2 trials
- Hidradenitis suppurativa2 trials
- Chronic spontaneous urticaria1 trial
- High blood pressure1 trial
- Myeloproliferative neoplasms1 trial
- Pulmonary arterial hypertension1 trial
- Stroke1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting9 trials
- Completed6 trials
- Recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals18 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Multiple sclerosis1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026